Case report: JAK inhibition as promising treatment option of fatal RVCLS due to TREX1 mutation (pVAL235Glyfs*6)

Overview of attention for article published in Frontiers in Neurology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 47,460 followers.

Case report: JAK inhibition as promising treatment option of fatal RVCLS due to TREX1 mutation (pVAL235Glyfs*6) https://t.co/ujTVoK79TH https://t.co/qo5LJyBcc9

13 Mar 2023

Reply Repost Favourite

RT @Brandon_Beaber: @Hematoxyline It's retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS). Here is…

13 Mar 2023

Reply Repost Favourite

@Hematoxyline It's retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCLS). Here is the case report: https://t.co/POA3MGI1bL

12 Mar 2023

Reply Repost Favourite

Case report: JAK inhibition as promising treatment option of fatal RVCLS due to TREX1 mutation (pVAL235Glyfs*6) https://t.co/P45gp3QDA4 https://t.co/fRL2JmrNUE

25 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.